August 2024
The global 7-Aminocephalosporanic Acid (7-ACA) market was estimated at US$ 671.2 million in 2023 and is projected to grow to US$ 1,264.68 million by 2034, rising at a compound annual growth rate (CAGR) of 5.54% from 2024 to 2034. The demand for 7-ACA is high in the market because it is a core component for the synthesis of cephalosporin.
Unlock Infinite Advantages: Subscribe to Annual Membership
The fundamental chemical structure, or synthon, for the production of cephalosporin antibiotics and intermediates, is 7-ACA (7-aminocephalosporanic acid). β-lactam antibiotics, known as cephalosporins, are used to treat a variety of illnesses brought on by both gram-positive and gram-negative bacteria. The treatment of meningitis, pneumonia, skin and soft tissue infections, and other diseases has been proven to be effective with the five generations of cephalosporins. The 7-Aminocephalosporanic Acid (7-ACA) market is growing due to the growing number of infections globally.
7-ACA is used as a component for the production of various antibiotics. These antibiotics are used in the treatment of various infections such as strep throat, pneumonia, ear infections, skin or soft tissue infections, meningitis, UTIs, sinus infections, and gonorrhea. As the population grows, the number of cases of infectious diseases is estimated to grow significantly. With a large number of patients with infections, the demand for antibiotics is going to grow in the future, which will promote the 7-Aminocephalosporanic Acid (7-ACA) market.
For instance,
Environmental Concerns
The 7-Aminocephalosporanic Acid (7-ACA) market faces challenges due to the pollution generated during the production of 7-ACA. The process includes various steps during which a lot of pollution is generated. Better and more sustainable procedures are being developed to tackle this challenge. However, balancing between cost, efficiency, and sustainability can be challenging.
North America is a well-established region known for its technological advancements, advanced healthcare infrastructure, growing R&D in biotechnology and pharmaceutical industries, presence of major market players, and government investments. All these factors work in the favour of the market’s growth. The two major countries that contribute to the market’s growth are the U.S. and Canada.
The U.S. has an advanced healthcare system that ensures that all the resources are available for timely treatment. Another factor that is promoting the 7-Aminocephalosporanic Acid (7-ACA) market’s growth is the growing number of various infectious diseases.
For instance,
The 7-Aminocephalosporanic Acid (7-ACA) market is growing in the region due to the growing number of cases of infectious diseases. Apart from this, governments, public and private organizations, research institutions, and others are making efforts to tackle the issue. The major countries that contribute to the market’s growth are China, India, Japan, and South Korea. Among these countries, China and India hold the second and third largest share of the pharmaceutical industry, respectively. It indicates that the production of antibiotics is done on a large scale for usage and export.
An estimated 134 million Indians are thought to be affected by chronic sinusitis, which can cause severe headaches, fever, nasal congestion, and blockage, among other symptoms. That exceeds the number of people living in Japan. Of the 1 393 400 000 persons in India, an estimated 57 251 328 (4.1%) have a severe fungal condition.
By product, the enzymatic hydrolysis segment dominated the 7-Aminocephalosporanic Acid (7-ACA) market in 2023. It is the process that produces 7-ACA the most frequently. The immobilized enzymes utilized in the method have the benefit of being readily recoverable from the reaction media and reusable several times due to their insolubility; this is a critical and essential requirement for an industrial process. The ability to easily recover the enzyme from the reaction mass not only makes it easier to recover the finished product but also allows the reaction solution from the first stage to be used directly in the second stage, which is another significant industrial benefit of the current invention.
By application, the ceftriaxone segment held the largest share of the 7-Aminocephalosporanic Acid (7-ACA) market in 2023. An antibiotic called ceftriaxone is administered intravenously by a medical professional at a hospital or clinic. It is a third-generation antibiotic made from 7-ACA cephalosporins. Because ceftriaxone is so well-liked in hospitals and clinics for infectious disorders, it exhibits good efficacy against the majority of gram-negative bacteria.
By Product
By Application
By Region
August 2024
December 2023
Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.